Latest On-Demand Webinars & Online Events

This inaugural event will showcase recent advances in the development of cell and gene therapies and the opportunities they provide for the treatment of disease and injury. Focus will be given to cancer immunotherapies and vaccines, stem cells, vector technologies and examples of genetic modification to treat a range of conditions.

Speaking at Cell & Gene Therapy 2023,Tracy Zhao from ACROBiosystems, presented their talk on products and services across cell therapy research and development.

Speaking at Cell and Gene Therapy 2023, Habib Malik from Bio-Techne, presented their talk on reproducible and easy-to-use immunoassay platforms.

Here, Dr. Riglar will discuss ways that we are using synthetic biology to solve this problem, and our quest to develop non-invasive living engineered bacterial tools – smart probiotics – to help us understand and control the gut and gut microbiota.

The 2023 Agilent BioTek Augmented Microscopy Virtual Summit offers a unique opportunity to learn about a wide variety of research applications being performed across the globe using BioTek cell imagers and cell imaging multimode readers. The online conference format enables individuals to attend talks, interact with presenters, and learn about the imaging technology and software being used to generate each result.

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics.

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics.

In this webinar, our expert speaker Dr. Ceri Fielding, from the division of infection and immunity at Cardiff University, will discuss the need to understand how viruses interact with NK cells during the development of novel antiviral therapies.

Design–build–test–learn (DBTL) cycles are commonly used in biotechnology and in natural product discovery as they provide a systemic and efficient framework for the metabolic engineering of microbes.

A novel platform that automates multiomics analyses of microbes could enable faster and better DBLT cycles for your research. In this webinar, the development and validation of the high-throughput, automated platform using model microbial organisms is described, as well as the recent work in applying the platform to cell factory and natural products engineering.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.